Search

Your search keyword '"Lip, Gregory YH"' showing total 948 results

Search Constraints

Start Over You searched for: Author "Lip, Gregory YH" Remove constraint Author: "Lip, Gregory YH"
948 results on '"Lip, Gregory YH"'

Search Results

3. Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation

4. Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group.

5. Cognitive Decline Over Time in Patients With Systolic Heart Failure Insights From WARCEF

7. Continuous infusion versus bolus injection of loop diuretics for acute heart failure

10. Non-Vitamin K Antagonist Oral Anticoagulants

11. Association between mortality and implantable cardioverter‐defibrillators by aetiology of heart failure: a propensity‐matched analysis of the WARCEF trial

12. Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment

15. Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)

21. Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients From the WARCEF Trial

22. Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure

23. International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives.

24. CHA2DS2‐VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm

25. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

26. Clinical trial evaluation: the EDOSURE clinical trial program.

28. Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure

29. Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

31. Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin

32. Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm

33. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

46. Conclusions

49. Recurrent Stroke in the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

Catalog

Books, media, physical & digital resources